Method Development And Validation Of Anti-cancer Drug: Doxorubicin | 6073
Journal of Analytical & Bioanalytical Techniques
Like us on:
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Doxorubicin is the one of the most potent antitumor drug of Bone Cancer, Breast
cancer. A simple and sensitive HPLC method was developed and validated
for the assay of doxorubicin. The method used a column C
with a UV. Detector is 254nm wavelength. The mobile phase consists of buffer
solution (Sodium Lauryl Sulphate & OrthoPhosphoric Acid): Acetonitrile. Flow rate
was found 1.0ml/min. All the system suitability parameter was found according to
the ICH standards. The method was extensively validated for specificity, linearity,
accuracy and precision, recovery robustness. The present assay of drugs was
found to be in range.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals